Lipocine Inc. — Investor Relations & Filings
Lipocine Inc. is a clinical-stage biopharmaceutical company that develops treatments for metabolic, endocrine, and central nervous system disorders. The company leverages its proprietary Lip'ral drug delivery technology to enhance the oral absorption of water-insoluble drugs, aiming to improve patient compliance and therapeutic outcomes. Its portfolio includes TLANDO®, an FDA-approved oral testosterone replacement therapy. Lipocine's development pipeline features candidates for conditions such as non-alcoholic steatohepatitis (NASH), postpartum depression, obesity, and prevention of preterm birth. The company's strategy often involves using the 505(b)(2) regulatory pathway to develop improved formulations of established drugs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-26 | English | |
| 8-K | 2026-05-19 | English | |
| 8-K | 2026-05-18 | English | |
| 8-K - Lipocine Inc. (0001535955) (Filer) | 2026-05-07 | English | |
| 10-Q - Lipocine Inc. (0001535955) (Filer) | 2026-05-07 | English | |
| DEF 14A - Lipocine Inc. (0001535955) (Filer) | 2026-04-21 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47073822 | 8-K | 2026-05-26 | English | ||
| 46538676 | 8-K | 2026-05-19 | English | ||
| 46385479 | 8-K | 2026-05-18 | English | ||
| 42975254 | 8-K - Lipocine Inc. (0001535955) (Filer) | 2026-05-07 | English | ||
| 42970442 | 10-Q - Lipocine Inc. (0001535955) (Filer) | 2026-05-07 | English | ||
| 34932534 | DEF 14A - Lipocine Inc. (0001535955) (Filer) | 2026-04-21 | English | ||
| 33160863 | 8-K - Lipocine Inc. (0001535955) (Filer) | 2026-04-02 | English | ||
| 33160633 | 8-K - Lipocine Inc. (0001535955) (Filer) | 2026-04-02 | English | ||
| 32893563 | 8-K - LIPOCINE INC. (0001535955) (Filer) | 2026-03-04 | English | ||
| 32893564 | 8-K - LIPOCINE INC. (0001535955) (Filer) | 2026-02-18 | English | ||
| 32893562 | 8-K - LIPOCINE INC. (0001535955) (Filer) | 2026-02-18 | English | ||
| 30451875 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30451877 | 8-K Filing | 2026-01-20 | English | ||
| 12525159 | 8-K | 2026-01-12 | English | ||
| 30451878 | 8-K Filing | 2026-01-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ARGENT BIOPHARMA LIMITED
Develops plant-inspired and synthetic medicines for neurolo…
|
RGT | AU | Manufacturing |
|
argenx SE
Develops and commercializes antibody-based therapies for se…
|
1AE | NL | Manufacturing |
|
Armata Pharmaceuticals, Inc.
Develops bacteriophage therapeutics for antibiotic-resistan…
|
ARMP | US | Manufacturing |
|
AroCell AB
Develops and markets in vitro diagnostic (IVD) tests for on…
|
AROC | SE | Manufacturing |
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
|
ARROWHEAD PHARMACEUTICALS, INC.
Biotechnology company developing RNAi therapies to treat in…
|
ARWR | US | Manufacturing |
|
ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for admini…
|
SPRY | US | Manufacturing |
|
ARTELO BIOSCIENCES, INC.
Clinical-stage biopharma developing therapeutics by modulat…
|
ARTL | US | Manufacturing |
|
Arura Pharma Inc
Diversified manufacturer and distributor in consumer goods …
|
— | CA | Manufacturing |
|
Ascelia Pharma
Biotechnology company developing and commercializing novel …
|
ACE | SE | Manufacturing |
Lipocine Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35074/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35074 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35074 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35074 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35074}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lipocine Inc. (id: 35074)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.